ADOREG - development and establishment of a nationwide prospective register for Health Services Research in dermatologic oncology

Organizational Data

DRKS-ID:
DRKS00006123
Recruitment Status:
Recruiting ongoing
Date of registration in DRKS:
2016-05-04
Last update in DRKS:
2016-05-04
Registration type:
Retrospective

Acronym/abbreviation of the study

ADOREG

URL of the study

No Entry

Brief summary in lay language

The aim of the project is a medical , information technology and organizational structure and operation of an online documentation system based on the applicable data protection regulations , in which all aspects and details of the treatment of dermatological tumors in clinical practice will be coverd , stored in a central database as a prospective registry and evaluated with analysis programs for various scientific and project-related issues. ADOREG is realized with the three sub- registers - Malignant Melanoma - Epithelial tumors - Actinic keratoses

Brief summary in scientific language

ADOREG is an electronic system / register for departments of skin cancer to enter all informations of health care and therapies of patients with skin cancer (Malignant Melanoma, Epithelial Tumors and Actinic Keratosis) to serve all informations for an academic evaluation.

Health condition or problem studied

Free text:
In Pilotphase Malignant Melanoma from Stage IIB, after pilotphase Epithelial Skin Cancer and Actinic Keratosis
ICD10:
C43-C44 - Melanoma and other malignant neoplasms of skin
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
prospective data collection in a register of patients with Skin Cancer: - Malignant Melanoma from Stage IIB (Pilotphase) - Epithelial Skin Cancer - Actinic Keratosis

Endpoints

Primary outcome:
Prospective informations about courses of treatments of patients with Malignant Melanoma from Stage IIB (Pilotphase) and also patients with epithelial Skin Cancer and Actinic Keratosis will begatherd via online portal ODM QuaSI. This is an unlimited register study.
Secondary outcome:
Process of Health Care and Therapy

Study Design

Purpose:
Treatment
Retrospective/prospective:
No Entry
Study type:
Non-interventional
Longitudinal/cross-sectional:
No Entry
Study type non-interventional:
No Entry

Recruitment

Recruitment Status:
Recruiting ongoing
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Multicenter study
Recruitment location(s):
  • Medical center Dermatologie Mannheim
  • Medical center Dermatologie Buxtehude
  • Medical center Dermatologie Mainz
  • Medical center Dermatologie Dresden
  • University medical center Dermatologie Essen
  • University medical center Dermatologie Kiel
  • Medical center Dermatologie München
  • Medical center Dermatologie Münster

Recruitment period and number of participants

Planned study start date:
No Entry
Actual study start date:
2013-09-15
Planned study completion date:
No Entry
Actual Study Completion Date:
No Entry
Target Sample Size:
20000
Final Sample Size:
No Entry

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
80 Years
Additional Inclusion Criteria:
- Malignant Melanoma from Stage IIB (Pilotphase) - Epithelial Skin Cancer - Actinic Keratosis

Exclusion Criteria

No sign / confirmation of Malignant Melanoma from Stage IIB, Epithelial Skin Cancers or Actinic Ceratosis

Addresses

Primary Sponsor

Address:
Uniklinik Essen, Hautklinik
Prof. Dr. Dirk Schadendorf
Hufelandstr. 55
45122 Esseb
Germany
Telephone:
+492017234342
Fax:
+492017235935
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.uk-essen.de/Hautklinik
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Uniklinik Essen, Hautklinik
Prof. Dr. Dirk Schadendorf
Hufelandstr. 55
45122 Esseb
Germany
Telephone:
+492017234342
Fax:
+492017235935
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.uk-essen.de/Hautklinik

Contact for Public Queries

Address:
Uniklinik Essen, Hautklinik
Prof. Dr. Dirk Schadendorf
Hufelandstr. 55
45122 Esseb
Germany
Telephone:
+492017234342
Fax:
+492017235935
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.uk-essen.de/Hautklinik

Principal Investigator

Address:
Uniklinik Essen, Hautklinik
Prof. Dr. Dirk Schadendorf
Hufelandstr. 55
45122 Esseb
Germany
Telephone:
+492017234342
Fax:
+492017235935
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.uk-essen.de/Hautklinik

Sources of Monetary or Material Support

Commercial (pharmaceutical industry, medical engineering industry, etc.)

Address:
ONKODATAMED
Friedenstr.58
15366 Neuhagen bei Berlin
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Private sponsorship (foundations, study societies, etc.)

Address:
Uniklinik Essen, Hautklinik
Hufelandstr. 55
45122 Essen
Germany
Telephone:
+492017234342
Fax:
+492017235935
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.uk-essen.de/Hautklinik

Ethics Committee

Address Ethics Committee

Address:
Ethik-Kommission der Medizinischen Fakultät der Universität Duisburg-Essen
Robert-Koch-Str. 9-11
45147 Essen
Germany
Telephone:
+49-201-7233637
Fax:
+49-201-7235837
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2013-02-11
Ethics committee number:
13-5359-BO
Vote of the Ethics Committee:
Approved
Date of the vote:
2013-09-11

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No Entry
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry